TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,628,230 | +1.4% | 255,323 | +2.0% | 0.82% | +2.6% |
Q2 2023 | $9,493,348 | +59.2% | 250,286 | +2.0% | 0.79% | +90.9% |
Q1 2023 | $5,964,893 | -8.9% | 245,267 | +8.8% | 0.42% | -27.4% |
Q4 2022 | $6,547,416 | -2.2% | 225,462 | +0.9% | 0.57% | -1.2% |
Q3 2022 | $6,697,022 | -16.0% | 223,383 | +1.4% | 0.58% | +2.3% |
Q2 2022 | $7,969,302 | -16.4% | 220,390 | +0.0% | 0.57% | -22.5% |
Q1 2022 | $9,529,572 | +5.0% | 220,286 | +21.6% | 0.73% | +26.2% |
Q4 2021 | $9,077,477 | -20.5% | 181,151 | +1.0% | 0.58% | -26.8% |
Q3 2021 | $11,413,059 | -9.0% | 179,366 | +2.9% | 0.79% | -5.3% |
Q2 2021 | $12,538,958 | +3.4% | 174,249 | +6.0% | 0.84% | -8.2% |
Q1 2021 | $12,122,878 | +8.4% | 164,378 | +8.0% | 0.91% | -30.5% |
Q4 2020 | $11,178,636 | +43.6% | 152,256 | +7.3% | 1.31% | -24.2% |
Q3 2020 | $7,782,612 | +11.3% | 141,889 | +34.9% | 1.73% | +80.3% |
Q2 2020 | $6,992,687 | +49.4% | 105,169 | +37.5% | 0.96% | -17.5% |
Q1 2020 | $4,679,291 | +974.4% | 76,459 | +1443.7% | 1.16% | +1410.4% |
Q4 2019 | $435,517 | – | 4,953 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
ARK Investment Management | 55,566 | $2,404,000 | 0.01% |